A Viral Vector CDMO Vision that Resonates

Avid Bioservices is leveraging decades of experience in quality manufacturing and regulatory excellence to the world of viral vectors. In the latest Pharma’s Almanac Q&A, “A Viral Vector CDMO Vision that Resonates,” hear from members of Avid’s leadership team about how our new, fit-for-purpose viral vector manufacturing facility delivers the ultimate customer experience, from facility tours to process monitoring.

This article provides insights into our new viral vector manufacturing facility and how its design emphasizes our core values of quality, flexibility, and collaboration. Discover Avid’s keys to success in process development and GMP manufacturing as well as our vision for unlocking the tremendous potential of cell and gene therapy.

Guests featured in the article include Drew Brennan, General Manager, Viral Vector; Rami Barghout, Director, Project Engineering; Elie Hanania, Ph.D., Vice President, Process Development Viral Vector; Chris Berger, Executive Director, Quality Viral Vector; and Dave Ingamells, Executive Director, GMP Operations Viral Vector.